These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 669970)
1. Renal transport of amino acids in children with oculocerebrorenal syndrome. Manz F; Bremer HJ; Brodehl J Helv Paediatr Acta; 1978 Apr; 33(1):37-44. PubMed ID: 669970 [TBL] [Abstract][Full Text] [Related]
2. [A genetic disease with a defect in biochemical sulfation--biochemical studies on Lowe's syndrome]. Yamashina I Tanpakushitsu Kakusan Koso; 1985 Jun; 30(7 Suppl):523-32. PubMed ID: 2999873 [No Abstract] [Full Text] [Related]
3. Uptake of proline in cultured cells from patients with Lowe's syndrome. States B; Palmieri MJ; Segal S Biochem Biophys Res Commun; 1982 Nov; 109(2):428-33. PubMed ID: 7181926 [No Abstract] [Full Text] [Related]
4. Clinical and laboratory findings in the oculocerebrorenal syndrome of Lowe, with special reference to growth and renal function. Charnas LR; Bernardini I; Rader D; Hoeg JM; Gahl WA N Engl J Med; 1991 May; 324(19):1318-25. PubMed ID: 2017228 [TBL] [Abstract][Full Text] [Related]
5. Impaired synthesis of intracellular heparan sulfate in skin fibroblasts of Lowe's syndrome. Yokoi T; Taniguchi N; Ikawa K J Lab Clin Med; 1982 Sep; 100(3):461-8. PubMed ID: 6213727 [TBL] [Abstract][Full Text] [Related]
6. Oculo-cerebro-renal syndrome (Lowe's syndrome)--a report of three cases. Curtis JA; Goel KM Practitioner; 1982 Jun; 226(1368):1159-64. PubMed ID: 7111150 [No Abstract] [Full Text] [Related]
7. Mitochondrial defects in Lowe's oculocerebrorenal syndrome. Gobernado JM; Lousa M; Gimeno A; Gonsalvez M Arch Neurol; 1984 Feb; 41(2):208-9. PubMed ID: 6691827 [TBL] [Abstract][Full Text] [Related]
8. [Cortical renal microcysts in Lowe's syndrome]. López Garrido J; Armas Padrón JR; González-Cámpora R; Galera Davidson H; Camacho González F; Estefanía Gallardo C An Esp Pediatr; 1985 Jun; 22(8):571-4. PubMed ID: 4051342 [TBL] [Abstract][Full Text] [Related]
9. Opacities of the lens indicating carrier status in the oculo-cerebro-renal (Lowe) syndrome. Delleman JW; Bleeker-Wagemakers EM; van Veelen AW J Pediatr Ophthalmol; 1977; 14(4):205-12. PubMed ID: 894443 [TBL] [Abstract][Full Text] [Related]
13. [Study of the SNC using MRI in a case of Lowe's syndrome]. Gabrielli O; Pierleoni C; Barbato M; Cecconi M; Coppa GV; Giorgi PL Pathologica; 1989; 81(1076):643-5. PubMed ID: 2635293 [TBL] [Abstract][Full Text] [Related]
14. [Biochemical and clinical renal symptoms in Lowe syndrome]. Chatys-Górska L; Zwolińska D; Prusek W Wiad Lek; 1980 Sep; 33(18):1477-82. PubMed ID: 6781146 [No Abstract] [Full Text] [Related]
15. [Hyperaminoaciduria: Toni-Fanconi and Lowe- syndrome]. Cantani A; Mastrantoni F Riv Eur Sci Med Farmacol; 1989 Apr; 11(2):123-8. PubMed ID: 2678306 [TBL] [Abstract][Full Text] [Related]
16. [An anesthetic experience of a patient with Lowe's syndrome (author's transl)]. Ishihara H; Nakamura T; Matsui M; Maeda A; Matsuki A; Oyama T Masui; 1979 Jan; 28(1):83-8. PubMed ID: 762887 [No Abstract] [Full Text] [Related]
17. Oral carnitine therapy in children with cystinosis and renal Fanconi syndrome. Gahl WA; Bernardini I; Dalakas M; Rizzo WB; Harper GS; Hoeg JM; Hurko O; Bernar J J Clin Invest; 1988 Feb; 81(2):549-60. PubMed ID: 3276734 [TBL] [Abstract][Full Text] [Related]